Clinical trials for the development of orphan medicinal products as defined in Regulation (EC) No 141/2000 of the European Parliament and of the Council and of medicinal products addressed to subjects affected by severe, debilitating and often life-threatening diseases affecting no more than one person in 50 000 in the Union (ultra-rare diseases) should be fostered.

https://eur-lex.europa.eu/lega (...) (...) [HTML] [2014-04-15]

Il convient d'encourager les essais cliniques pour la mise au point de médicaments orphelins au sens du règlement (CE) no 141/2000 du Parlement européen et du Conseil et de médicaments destinés aux patients atteints de maladies lourdes, invalidantes et, souvent, mettant la vie en danger qui ne touchent pas plus d'une personne sur 50 000 dans l'Union (maladies ultra-rares).

https://eur-lex.europa.eu/lega (...) (...) [HTML] [2014-04-15]

https://eur-lex.europa.eu/lega (...) [HTML] [2014-04-15]

(9) Clinical trials for the development of orphan medicinal products as defined in Regulation (EC) No 141/2000 of the European Parliament and of the Council and of medicinal products addressed to subjects affected by severe, debilitating and often life-threatening diseases affecting no more than one person in 50 000 in the Union (ultra-rare diseases) should be fostered.

http://www.europarl.europa.eu/ (...) (...) [HTML] [2014-04-01]

(9) Il convient d'encourager les essais cliniques pour la mise au point de médicaments orphelins au sens du règlement (CE) n° 141/2000 du Parlement européen et du Conseil et de médicaments destinés aux patients atteints de maladies lourdes, invalidantes et, souvent, mettant la vie en danger qui ne touchent pas plus d'une personne sur 50 000 dans l'Union (maladies très rares).

http://www.europarl.europa.eu/ (...) (...) [HTML] [2014-04-01]

http://www.europarl.europa.eu/ (...) [HTML] [2014-04-01]

Clinical trials for the development of orphan medicinal products as defined in Regulation (EC) No 141/2000 of the European Parliament and of the Council (4) and of medicinal products addressed to subjects affected by severe, debilitating and often life-threatening diseases affecting no more than one person in 50 000 in the Union (ultra-rare diseases) should be fostered.

http://eur-lex.europa.eu/legal (...) (...) [HTML] [2013-12-31]

Il convient d'encourager les essais cliniques pour la mise au point de médicaments orphelins au sens du règlement (CE) no 141/2000 du Parlement européen et du Conseil (4) et de médicaments destinés aux patients atteints de maladies lourdes, invalidantes et, souvent, mettant la vie en danger qui ne touchent pas plus d'une personne sur 50 000 dans l'Union (maladies ultra-rares).

http://eur-lex.europa.eu/legal (...) (...) [HTML] [2013-12-31]

http://eur-lex.europa.eu/legal (...) [HTML] [2013-12-31]

Others have searched : genetic orphan disease orphan disease rare disease ultra-orphan disease ultra-rare disease

www.wordscope.com (v4.0.br.77)

'ultra-orphan disease'

Date index:2022-02-28 -

Pour agences de traduction et traducteurs - For translation agencies & translators

Paris - Brussels - Montreal - Genève - Luxembourg - Madrid

Wordscope - Professional computer-assisted translation tools (CAT tools)

Translation of "ultra-orphan disease " (English → French) :

Pour agences de traduction et traducteurs - For translation agencies & translators Paris - Brussels - Montreal - Genève - Luxembourg - Madrid Wordscope - Professional computer-assisted translation tools (CAT tools)

Pour agences de traduction et traducteurs - For translation agencies & translators

Paris - Brussels - Montreal - Genève - Luxembourg - Madrid

Wordscope - Professional computer-assisted translation tools (CAT tools)